{
  "patientId": "44556",
  "demographics": {
    "name": "John Smith",
    "dob": "1970-07-12",
    "gender": "Male",
    "address": "456 Oak Avenue, Anytown, USA",
    "phone": "555-4455",
    "insurance": "BlueCross BlueShield",
    "referringPhysician": "Dr. Alice Brown (Neurology)",
    "emergencyContact": "Jane Smith (Wife) - 555-4456",
    "advanceDirectives": "Full Code (Verified 03/24/2025)",
    "supportServices": "Social Work consult placed 03/25/25 for coping support.",
    "mobility": "Ambulates independently, no assistive devices needed at baseline."
  },
  "diagnosis": {
    "primary": "Glioblastoma, WHO Grade IV",
    "location": "Right Temporal Lobe",
    "dateInitialSymptoms": "~February 10, 2025",
    "datePathologicDiagnosis": "03/16/2025 (Post-resection)",
    "symptomsAtPresentation": "New onset focal seizures (left arm twitching), persistent headache unresponsive to OTC meds, subtle personality changes reported by wife.",
    "baselineNeuroStatus": "ECOG 1 (Symptomatic but fully ambulatory)",
    "pathologyFindings": [
      "High-grade astrocytic neoplasm.",
      "Features include significant cellular pleomorphism, high mitotic activity, microvascular proliferation, and palisading necrosis.",
      "Immunohistochemistry: GFAP positive, ATRX retained, IDH1 R132H negative.",
      "Molecular: IDH-wildtype, MGMT promoter unmethylated."
    ],
    "priorTreatmentSummary": "Maximal safe surgical resection (03/15/2025) by Dr. Robert White (Neurosurgery)"
  },
  "treatmentPlan": {
    "radOnc": "Dr. Evelyn Reed",
    "neuroOnc": "Dr. Michael Chen",
    "treatmentSite": "Right Temporal Lobe",
    "intent": "Adjuvant (Post-operative)",
    "modality": "External Beam Radiation Therapy (EBRT) with concurrent Temozolomide (TMZ)",
    "rtRxDetails": "60 Gy in 30 fractions (2 Gy/fx)",
    "targetVolumeSummary": "Post-operative tumor bed with margins, treated via two VMAT arcs.",
    "techniqueSummary": "Volumetric Modulated Arc Therapy (VMAT) used to deliver a highly conformal dose distribution, sparing critical structures.",
    "concurrentChemo": "Temozolomide 75 mg/m^2 PO Daily during radiation (Managed by Dr. Chen)",
    "medications": [
      "Dexamethasone 2 mg PO BID (Tapering schedule planned)",
      "Levetiracetam 750 mg PO BID (for seizure prophylaxis)",
      "Ondansetron PRN Nausea (related to TMZ)"
    ],
    "therapistAlerts": [
      "Monitor for seizure activity pre/post treatment.",
      "Patient may experience mild confusion post-treatment; ensure he has his way home planned.",
      "High risk for fatigue; encourage patient to rest as needed."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "03/28/2025",
      "setupInstructions": "Supine, head neutral in custom Aquaplast mask indexed to table. Patient aligned to room lasers using anterior and bilateral marks on mask.",
      "immobilization": "Custom Aquaplast thermoplastic mask",
      "referenceMarks": "3-point marks on thermoplastic mask aligned to room lasers. Isocenter set at L-1.5, L+2.0, V+5.0 relative to CT sim reference point.",
      "setupImages": ["JS44556_setup_ap.jpg", "JS44556_setup_lat.jpg"]
    },
    "dosimetry": {
      "planId": "JS44556_GBM",
      "planStatus": "Final - Approved by Dr. Evelyn Reed",
      "rx": "60 Gy / 30 fx",
      "technique": "VMAT",
      "energy": "6MV FFF",
      "numberOfFieldsOrArcs": 2,
      "gantryAngles": "Arc 1: 181-179 CW, Arc 2: 179-181 CCW",
      "collAngles": "30, 330",
      "couchAngles": "0",
      "isoCoords": "L-1.5, L+2.0, V+5.0",
      "tps": "Eclipse",
      "algorithm": "AcurosXB",
      "hetero": "Yes",
      "norm": "PTV Mean 99.5% receives 60Gy",
      "constraints": "Brainstem Max < 54 Gy; Chiasm Max < 54 Gy; R Optic Nrv Max < 54 Gy; L Optic Nrv Max < 54 Gy. All constraints met.",
      "planNotes": "Standard of care adjuvant chemoradiation for GBM.",
      "igrtProtocol": {
          "frequency": "Daily",
          "type": "CBCT",
          "alignment": "Bony anatomy of the skull"
      },
      "qaChecks": [
          { "date": "2025-04-01", "type": "Initial Chart Check", "by": "Physics Staff" },
          { "date": "2025-04-01", "type": "Patient Specific QA", "by": "Physics Staff", "result": "Pass (Gamma 99.7% @ 3%/2mm)"}
      ],
      "fieldDetails": [
        { "fieldName": "Arc 1", "fieldSize": "Dynamic MLC", "gantryAngle": "181-179 CW", "collimatorAngle": "30", "couchAngle": "0", "energy": "6MV FFF", "monitorUnits": 348, "ssd": "Variable" },
        { "fieldName": "Arc 2", "fieldSize": "Dynamic MLC", "gantryAngle": "179-181 CCW", "collimatorAngle": "330", "couchAngle": "0", "energy": "6MV FFF", "monitorUnits": 355, "ssd": "Variable" }
      ]
    },
    "treatmentDelivery": {
      "fractions": [
        {
          "fractionNumber": 1,
          "date": "2025-04-02",
          "machine": "LINAC2",
          "setupNotes": "Daily CBCT performed, matched to bony anatomy. No adjustments needed. Patient tolerated procedure well.",
          "sideEffects": "None reported.",
          "notes": "First day of treatment. Patient anxious but cooperative. Reinforced education on side effect management.",
          "recordedFields": [
            { "fieldName": "Arc 1", "deliveredMu": 348, "notes": "Tolerance met" },
            { "fieldName": "Arc 2", "deliveredMu": 355, "notes": "Tolerance met" }
          ]
        },
        {
          "fractionNumber": 2,
          "date": "2025-04-03",
          "machine": "LINAC2",
          "setupNotes": "Daily CBCT. Shifts applied: Vrt: -0.1, Lng: 0.0, Lat: +0.2. Tolerances met post-shift.",
          "sideEffects": "Reports mild headache, resolved with OTC analgesic.",
          "notes": "Continue to monitor.",
           "recordedFields": [
            { "fieldName": "Arc 1", "deliveredMu": 348, "notes": "Tolerance met" },
            { "fieldName": "Arc 2", "deliveredMu": 355, "notes": "Tolerance met" }
          ]
        }
      ]
    }
  },
  "imagingAndReports": [
    {
      "date": "02/25/2025",
      "type": "MRI Brain w/ & w/o Contrast (Pre-Op)",
      "summary": "Large (4.5 cm) heterogeneously enhancing mass in R temporal lobe, suspicious for HGG.",
      "reportDetails": {
        "fullSummary": "Large (4.5 cm) heterogeneously enhancing mass in the right temporal lobe with significant surrounding vasogenic edema and mass effect, causing midline shift of 4mm. Findings suspicious for high-grade glioma."
      }
    },
    {
      "date": "03/16/2025",
      "type": "Surgical Pathology Report",
      "summary": "Glioblastoma, WHO Grade IV, IDH-wt, MGMT-unmethylated.",
      "reportDetails": {
        "accessionNumber": "S25-12345",
        "specimenSource": "Right temporal lobe mass, resection",
        "finalDiagnosis": "GLIOBLASTOMA, IDH-WILDTYPE (WHO GRADE 4).",
        "microscopicDescription": "Sections show a hypercellular, diffusely infiltrating astrocytic glioma. Tumor cells exhibit marked nuclear pleomorphism and frequent, atypical mitotic figures. Microvascular proliferation and pseudopalisading necrosis are prominent. No pathogenic IDH1 R132H or IDH2 R172 mutations are identified by immunohistochemistry and sequencing. MGMT promoter methylation analysis is negative (unmethylated).",
        "comment": "The histologic and molecular features are diagnostic of glioblastoma, IDH-wildtype, WHO Grade 4."
      }
    },
    {
      "date": "03/28/2025",
      "type": "CT Simulation (Head)",
      "summary": "Non-contrast CT for RT planning, fused with post-op MRI.",
      "reportDetails": {
        "fullSummary": "Non-contrast CT head acquired in treatment position with thermoplastic mask immobilization for RT planning. Scan fused with post-op MRI (03/16/2025) for target delineation."
      }
    }
  ],
  "dicomImages": [],
  "labResults": [],
  "progressNotes": [],
  "patientEducation": {},
  "scheduling": [],
  "cptCharges": [],
  "diagnosisSearch": "Glioblastoma"
}
